Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 411771000001113 | DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Pilsco Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 411781000001110 | DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Pilsco Ltd) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1419891000001119 | DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Ethigen Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1419901000001118 | DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Ethigen Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Ethigen Ltd) 120 dose | Has AMP | True | DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Ethigen Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets